n-methyl-3,4-methylenedioxyamphetamine has been researched along with Depression in 63 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine treatment reversed MDMA-induced anxiety in the emergence test and depressive-like effects in the forced swim test, yet exhibited no effects on the social interaction test." | 5.32 | Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. ( Clemens, KJ; Cornish, JL; Gurtman, CG; Hunt, GE; Li, KM; McGregor, IS; Thompson, MR, 2004) |
| " Our experiments were designed to examine the effects of a concomitant administration of 3,4-methylenedioxy-methamphetamine (MDMA) and mephedrone on depression- and anxiety-like behaviors and cognitive processes in Swiss mice." | 3.85 | Acute behavioral effects of co-administration of mephedrone and MDMA in mice. ( Biała, G; Budzynska, B; Frankowska, M; Kaszubska, K; Michalak, A, 2017) |
| "Examine the severity of club drug dependence and perceived need for treatment, and further identify their determinants among a sample of club drug users in Shanghai, China." | 1.40 | Severity of club drug dependence and perceived need for treatment among a sample of adult club drug users in Shanghai, China. ( Detels, R; Ding, Y; Gao, M; He, N; Shoptaw, S, 2014) |
| "These results indicate that hyperthermia at the time of dosing with MDMA is not necessary to produce subsequent 5-HT depletion and anxiety in rats." | 1.32 | Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes. ( Blokland, A; Clemens, KJ; Cornish, JL; Gurtman, CG; Hunt, GE; Li, KM; McGregor, IS; Morley, KC, 2003) |
| "Fluoxetine treatment reversed MDMA-induced anxiety in the emergence test and depressive-like effects in the forced swim test, yet exhibited no effects on the social interaction test." | 1.32 | Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. ( Clemens, KJ; Cornish, JL; Gurtman, CG; Hunt, GE; Li, KM; McGregor, IS; Thompson, MR, 2004) |
| "Additionally, users that met DSM-IV substance use disorder criteria for lifetime MDMA abuse or dependence exhibited a number of additional deficits relative to those who did not meet these criteria." | 1.32 | Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use. ( Hanson, KL; Luciana, M, 2004) |
| "The long-term use of the serotonin-releaser and uptake-inhibitor 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") has been associated with memory impairments and increased liability to depressive mood and anxiety attacks." | 1.31 | No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study. ( Berthold, T; Buck, A; Gamma, A; Vollenweider, FX, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.59) | 18.7374 |
| 1990's | 3 (4.76) | 18.2507 |
| 2000's | 33 (52.38) | 29.6817 |
| 2010's | 20 (31.75) | 24.3611 |
| 2020's | 6 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Pantoni, MM | 1 |
| Kim, JL | 1 |
| Van Alstyne, KR | 1 |
| Anagnostaras, SG | 1 |
| Yang, KH | 1 |
| Han, BH | 1 |
| Palamar, JJ | 1 |
| Haridy, R | 1 |
| Nogrady, B | 1 |
| Reardon, S | 1 |
| Tullis, P | 1 |
| Kuypers, KPC | 1 |
| de la Torre, R | 1 |
| Farre, M | 1 |
| Xicota, L | 1 |
| de Sousa Fernandes Perna, EB | 1 |
| Theunissen, EL | 1 |
| Ramaekers, JG | 2 |
| Shih, JH | 1 |
| Chiu, CH | 1 |
| Ma, KH | 1 |
| Huang, YS | 1 |
| Shiue, CY | 1 |
| Yeh, TY | 1 |
| Kao, LT | 1 |
| Lin, YY | 1 |
| Li, IH | 1 |
| George, AM | 1 |
| Olesen, S | 1 |
| Tait, RJ | 1 |
| Ding, Y | 1 |
| He, N | 1 |
| Shoptaw, S | 1 |
| Gao, M | 1 |
| Detels, R | 1 |
| Scott, RM | 3 |
| Hides, L | 3 |
| Allen, JS | 3 |
| Lubman, DI | 3 |
| Taurah, L | 1 |
| Chandler, C | 1 |
| Sanders, G | 1 |
| Wetherell, MA | 1 |
| Montgomery, C | 1 |
| Turner, JJ | 1 |
| Parrott, AC | 2 |
| Goodwin, J | 1 |
| Moore, DG | 1 |
| Fulton, S | 1 |
| Min, MO | 1 |
| Singer, LT | 1 |
| Fulde, GW | 1 |
| Forster, SL | 1 |
| Budzynska, B | 1 |
| Michalak, A | 1 |
| Frankowska, M | 1 |
| Kaszubska, K | 1 |
| Biała, G | 1 |
| Green, A | 1 |
| Marsden, C | 1 |
| Fone, K | 1 |
| Scheier, LM | 1 |
| Ben Abdallah, A | 1 |
| Inciardi, JA | 1 |
| Copeland, J | 1 |
| Cottler, LB | 1 |
| Bedi, G | 1 |
| Van Dam, NT | 1 |
| Redman, J | 1 |
| Daniulaityte, R | 1 |
| Falck, RS | 2 |
| Wang, J | 2 |
| Carlson, RG | 2 |
| Kelly, BC | 2 |
| León, LA | 1 |
| Landeira-Fernandez, J | 1 |
| Cardenas, FP | 1 |
| Bissette, G | 1 |
| Schilt, T | 1 |
| Koeter, MW | 1 |
| Smal, JP | 1 |
| Gouwetor, MN | 1 |
| van den Brink, W | 2 |
| Schmand, B | 1 |
| Burke, R | 1 |
| Jaehne, EJ | 1 |
| Majumder, I | 1 |
| Salem, A | 1 |
| Irvine, RJ | 1 |
| Matthews, AJ | 1 |
| Bruno, R | 1 |
| Nichols, D | 1 |
| Fernando, T | 1 |
| Gilbert, JD | 1 |
| Carroll, CM | 1 |
| Byard, RW | 1 |
| Brière, FN | 1 |
| Fallu, JS | 1 |
| Janosz, M | 1 |
| Pagani, LS | 1 |
| Potter, A | 1 |
| Downey, L | 1 |
| Stough, C | 2 |
| MacInnes, N | 2 |
| Handley, SL | 2 |
| Harding, GF | 2 |
| Buchanan, T | 1 |
| Scholey, AB | 1 |
| Heffernan, T | 1 |
| Ling, J | 1 |
| Rodgers, J | 1 |
| McGregor, IS | 2 |
| Gurtman, CG | 2 |
| Morley, KC | 1 |
| Clemens, KJ | 2 |
| Blokland, A | 1 |
| Li, KM | 2 |
| Cornish, JL | 2 |
| Hunt, GE | 2 |
| Verheyden, SL | 2 |
| Henry, JA | 2 |
| Curran, HV | 3 |
| Thompson, MR | 1 |
| Roiser, JP | 1 |
| Sahakian, BJ | 1 |
| Hanson, KL | 1 |
| Luciana, M | 1 |
| McCardle, K | 1 |
| Luebbers, S | 1 |
| Carter, JD | 1 |
| Croft, RJ | 1 |
| De Almeida, SP | 1 |
| Silva, MT | 1 |
| Diamond, GM | 1 |
| Izzard, MC | 1 |
| Kedar, T | 1 |
| Hutlzer, A | 1 |
| Mell, H | 1 |
| Uys, JD | 1 |
| Niesink, RJ | 1 |
| Hoshi, R | 1 |
| Pratt, H | 1 |
| Mehta, S | 1 |
| Bond, AJ | 1 |
| Lamers, CT | 1 |
| Bechara, A | 1 |
| Rizzo, M | 1 |
| Medina, KL | 1 |
| Shear, PK | 1 |
| Reid, LW | 1 |
| Elifson, KW | 1 |
| Sterk, CE | 1 |
| Guillot, C | 1 |
| Sessa, B | 1 |
| Nutt, DJ | 1 |
| Cohen, RS | 1 |
| Pennings, EJ | 1 |
| Konijn, KZ | 1 |
| de Wolff, FA | 2 |
| Gamma, A | 1 |
| Buck, A | 1 |
| Berthold, T | 1 |
| Vollenweider, FX | 1 |
| O'Leary, G | 1 |
| Nargiso, J | 1 |
| Weiss, RD | 1 |
| Reneman, L | 1 |
| Booij, J | 1 |
| de Bruin, K | 1 |
| Reitsma, JB | 1 |
| Gunning, WB | 1 |
| den Heeten, GJ | 1 |
| Cole, JC | 1 |
| Sumnall, HR | 1 |
| Hadfield, J | 1 |
| Calin, T | 1 |
| Haddad, PM | 1 |
| Strickland, P | 1 |
| Anderson, I | 1 |
| Deakin, JF | 1 |
| Dursun, SM | 1 |
| Ratzenböck, E | 1 |
| Whitaker-Azmitia, PM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Neurotoxicity of Ecstasy: Causality, Course and Clinical Relevance[NCT00235768] | 225 participants | Observational | 2002-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Depression
| Article | Year |
|---|---|
MDMA and memory, addiction, and depression: dose-effect analysis.
Topics: Amnesia; Animals; Conditioning, Classical; Depression; Dose-Response Relationship, Drug; Fear; Mice; | 2022 |
The impact of amphetamine-type stimulants on emergency services.
Topics: Acute Disease; Aggression; Amphetamine; Amphetamine-Related Disorders; Anxiety; Central Nervous Syst | 2015 |
Does Alzheimer's disease result from attempts at repair or protection after transient stress?
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Craniocerebral Tr | 2009 |
Pharmacological aspects of the combined use of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and gamma-hydroxybutyric acid (GHB): a review of the literature.
Topics: Anxiety; Body Temperature; Depression; Dopamine; Hallucinogens; Humans; Hydroxybutyrates; N-Methyl-3 | 2005 |
Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms?
Topics: Affect; Depression; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; Psychiatric Statu | 2007 |
[Clinical and toxicologic aspects of the use of Ecstasy].
Topics: Animals; Axons; Brain Chemistry; Depression; Female; Fever; Humans; Impulsive Behavior; Inappropriat | 1998 |
3,4-methylenedioxymethamphetamine (MDMA): a review.
Topics: Brain; Depression; Hallucinogens; Humans; Malignant Hyperthermia; N-Methyl-3,4-methylenedioxyampheta | 2001 |
2 trials available for n-methyl-3,4-methylenedioxyamphetamine and Depression
| Article | Year |
|---|---|
An investigation into the sub-acute effects of ecstasy on aggressive interpretative bias and aggressive mood - are there gender differences?
Topics: Adult; Affect; Aggression; Alcoholic Intoxication; Amphetamine-Related Disorders; Anxiety; Attention | 2006 |
Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls.
Topics: Adult; Amphetamine-Related Disorders; Anxiety; Cognition Disorders; Decision Making; Depression; Dis | 2006 |
54 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Depression
| Article | Year |
|---|---|
Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults.
Topics: Adult; Depression; Depressive Disorder, Major; Hallucinogens; Humans; Lysergic Acid Diethylamide; N- | 2022 |
Australia to prescribe MDMA and psilocybin for PTSD and depression in world first.
Topics: Australia; Depression; Drug Approval; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; St | 2023 |
Australia's approval of MDMA and psilocybin for PTSD and depression is premature, say critics.
Topics: Australia; Depression; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Stress Disorders, | 2023 |
Psychedelic treatments are speeding towards approval - but no one knows how they work.
Topics: Depression; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psilocybin; Psychological | 2023 |
How ecstasy and psilocybin are shaking up psychiatry.
Topics: Animals; Certification; Clinical Trials as Topic; Depression; Depressive Disorder, Treatment-Resista | 2021 |
Depressive mood ratings are reduced by MDMA in female polydrug ecstasy users homozygous for the l-allele of the serotonin transporter.
Topics: Adolescent; Adult; Affect; Alleles; Depression; Drug Users; Female; Genetic Predisposition to Diseas | 2018 |
Autophagy inhibition plays a protective role against 3, 4-methylenedioxymethamphetamine (MDMA)-induced loss of serotonin transporters and depressive-like behaviors in rats.
Topics: Adenine; Animals; Autophagy; Behavior, Animal; Brain; Depression; Male; N-Methyl-3,4-methylenedioxya | 2019 |
Ecstasy use and depression: a 4-year longitudinal study among an Australian general community sample.
Topics: Adult; Australia; Depression; Female; Humans; Longitudinal Studies; Male; Multivariate Analysis; N-M | 2013 |
Severity of club drug dependence and perceived need for treatment among a sample of adult club drug users in Shanghai, China.
Topics: Adolescent; Adult; China; Depression; Drug Users; Female; Humans; Illicit Drugs; Male; Motivation; N | 2014 |
Coping style and ecstasy use motives as predictors of current mood symptoms in ecstasy users.
Topics: Adaptation, Psychological; Adolescent; Adult; Affective Symptoms; Anxiety; Australia; Child; Cross-S | 2013 |
Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
Topics: Adolescent; Adult; Alcohol-Related Disorders; Amphetamine-Related Disorders; Attitude to Health; Dep | 2014 |
Basal functioning of the hypothalamic-pituitary-adrenal (HPA) axis and psychological distress in recreational ecstasy polydrug users.
Topics: Anxiety; Case-Control Studies; Circadian Rhythm; Depression; Drug Users; Female; Humans; Hydrocortis | 2014 |
Psychiatric profiles of mothers who take Ecstasy/MDMA during pregnancy: reduced depression 1 year after giving birth and quitting Ecstasy.
Topics: Adult; Case-Control Studies; Depression; Drug Users; Female; Health Status; Humans; Illicit Drugs; M | 2014 |
Acute behavioral effects of co-administration of mephedrone and MDMA in mice.
Topics: Animals; Antidepressive Agents; Anxiety; Cognition; Depression; Disease Models, Animal; Drug Interac | 2017 |
MDMA as a clinical tool: a note of caution. A response to Sessa and Nutt.
Topics: Animals; Depression; Dopamine; Electroconvulsive Therapy; Humans; N-Methyl-3,4-methylenedioxyampheta | 2008 |
Tri-city study of Ecstasy use problems: a latent class analysis.
Topics: Adult; Amphetamine-Related Disorders; Depression; Family; Female; Hallucinogens; Humans; Logistic Mo | 2008 |
Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
Topics: Adolescent; Adult; Anxiety; Depression; Female; Hallucinogens; Humans; Male; Marijuana Abuse; Multiv | 2010 |
Illicit use of pharmaceutical opioids among young polydrug users in Ohio.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Analgesics, Opioid; Depression; Diagnosis, Dual (P | 2009 |
Mediating MDMA-related harm: preloading and post-loading among Ecstasy-using youth.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Antidepressive Agents; Antidepressive Agents, Seco | 2009 |
Effects of chronic intracerebroventricular 3,4-methylenedioxy-N-methamphetamine (MDMA) or fluoxetine on the active avoidance test in rats with or without exposure to mild chronic stress.
Topics: Analysis of Variance; Animals; Avoidance Learning; Chronic Disease; Depression; Disease Models, Anim | 2009 |
Long-term neuropsychological effects of ecstasy in middle-aged ecstasy/polydrug users.
Topics: Adult; Age Factors; Attention; Cross-Sectional Studies; Depression; Female; Hallucinogens; Humans; I | 2010 |
Depressive and anxiety symptomatology in ecstasy users: the relative contribution of genes, trauma, life stress and drug use.
Topics: Adolescent; Adult; Affect; Anxiety; Depression; Female; Hallucinogens; Humans; Male; N-Methyl-3,4-me | 2010 |
Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Arousal; Body Temperature Regulation; Brain; Cerebral Corte | 2011 |
An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers.
Topics: Adolescent; Adult; Chi-Square Distribution; Depression; Female; Humans; Male; N-Methyl-3,4-methylene | 2010 |
Legal highs: the dark side of medicinal chemistry.
Topics: Amphetamines; Animals; Depression; Designer Drugs; Drug Design; Electronic Mail; Hallucinogens; Huma | 2011 |
Ecstasy and suicide.
Topics: Adolescent; Depression; Female; Forensic Pathology; Forensic Toxicology; Hallucinogens; Humans; Live | 2012 |
Prospective associations between meth/amphetamine (speed) and MDMA (ecstasy) use and depressive symptoms in secondary school students.
Topics: Adolescent; Amphetamine-Related Disorders; Central Nervous System Stimulants; Depression; Female; Hu | 2012 |
Subacute effects of ecstasy on mood: an exploration of associated risk factors.
Topics: Adult; Affect; Anxiety; Depression; Female; Follow-Up Studies; Humans; Male; Mental Disorders; N-Met | 2013 |
Cognitive function in ecstasy naive abstinent drug dependants and MDMA users.
Topics: Adult; Affect; Case-Control Studies; Cognition; Depression; Drug Users; Female; Humans; Illicit Drug | 2013 |
The BDI of the beholder: an eye to experimental design.
Topics: Depression; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Personality Inventory; Psychometrics; Ra | 2002 |
Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users.
Topics: Anxiety; Depression; Humans; Illicit Drugs; Internet; Memory Disorders; N-Methyl-3,4-methylenedioxya | 2002 |
Increased anxiety and "depressive" symptoms months after MDMA ("ecstasy") in rats: drug-induced hyperthermia does not predict long-term outcomes.
Topics: Amygdala; Animals; Anxiety; Biogenic Monoamines; Cognition; Corpus Striatum; Depression; Fever; Hipp | 2003 |
Acute, sub-acute and long-term subjective consequences of 'ecstasy' (MDMA) consumption in 430 regular users.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Attention; Depression; England; Female; Hallucinog | 2003 |
Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats.
Topics: Animals; Antidepressive Agents, Second-Generation; Anxiety; Body Fluids; Body Temperature; Body Weig | 2004 |
Relationship between ecstasy use and depression: a study controlling for poly-drug use.
Topics: Adult; Attention; Bias; Depression; Emotions; Female; Humans; Illicit Drugs; Male; N-Methyl-3,4-meth | 2004 |
Neurocognitive function in users of MDMA: the importance of clinically significant patterns of use.
Topics: Adolescent; Adult; Brain; Cognition Disorders; Depression; Diagnostic and Statistical Manual of Ment | 2004 |
Chronic MDMA (ecstasy) use, cognition and mood.
Topics: Adult; Affect; Cognition; Depression; Female; Humans; Male; N-Methyl-3,4-methylenedioxyamphetamine; | 2004 |
Characteristics of ecstasy users in Sãio Paulo, Brazil.
Topics: Adult; Anxiety; Brazil; Catchment Area, Health; Depression; Disruptive, Impulse Control, and Conduct | 2005 |
Psychological symptoms and drug use severity among Israeli adolescents presenting for outpatient drug abuse treatment.
Topics: Adolescent; Ambulatory Care; Attention Deficit and Disruptive Behavior Disorders; Depression; Female | 2005 |
Conceptions of risk in the lives of club drug-using youth.
Topics: Adolescent; Adult; Anthropology, Cultural; Attitude to Health; Depression; Female; Hallucinogens; He | 2005 |
Anxiety, depression, and behavioral symptoms of executive dysfunction in ecstasy users: contributions of polydrug use.
Topics: Affect; Anxiety; Behavioral Symptoms; Depression; Female; Humans; Male; N-Methyl-3,4-methylenedioxya | 2007 |
Hug drug or thug drug? Ecstasy use and aggressive behavior.
Topics: Adult; Affect; Aggression; Amphetamine-Related Disorders; Anxiety; Attention; Concept Formation; Dep | 2007 |
MDMA, politics and medical research: have we thrown the baby out with the bathwater?
Topics: Affect; Biomedical Research; Depression; Humans; Legislation, Drug; N-Methyl-3,4-methylenedioxyamphe | 2007 |
Depressive symptomatology in young adults with a history of MDMA use: a longitudinal analysis.
Topics: Adolescent; Adult; Amphetamine-Related Disorders; Depression; Female; Humans; Longitudinal Studies; | 2008 |
Ecstasy and serotonin depletion.
Topics: Animals; Depression; Hallucinogens; Humans; Illicit Drugs; N-Methyl-3,4-methylenedioxyamphetamine; T | 1996 |
Subjective reports on the effects of the MDMA ('ecstasy') experience in humans.
Topics: Adolescent; Adult; Anxiety; Behavior; Depression; Female; Humans; Male; N-Methyl-3,4-methylenedioxya | 1995 |
No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study.
Topics: Adult; Affect; Age Factors; Arousal; Brain; Cognition; Depression; Female; Hallucinogens; Humans; Ma | 2001 |
Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms.
Topics: Adult; Depression; Female; Humans; Internal-External Control; Life Change Events; Male; Motivation; | 2001 |
Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.
Topics: Adult; Binding Sites; Brain; Case-Control Studies; Depression; Dose-Response Relationship, Drug; Fem | 2001 |
The BDI of the beholder.
Topics: Depression; Hallucinogens; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Psychiatric Status Rating | 2002 |
Sub-acute effects of MDMA (+/-3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences.
Topics: Adolescent; Adult; Affect; Aggression; Depression; Female; Humans; Male; N-Methyl-3,4-methylenedioxy | 2002 |
Effects of MDMA (ecstasy) use and abstention on serotonin neurons.
Topics: Adult; Binding Sites; Brain; Depression; Dose-Response Relationship, Drug; Female; Humans; Male; N-M | 2002 |
Effects of MDMA (ecstasy) use and abstention on serotonin neurons.
Topics: Adult; Binding Sites; Brain; Depression; Dose-Response Relationship, Drug; Female; Humans; Male; N-M | 2002 |
Depression to ecstasy. The Neuropharmacology of Serotonin sponsored by the New York Academy of Sciences, New York, NY, USA, July 10-13, 1989.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Mapping; Depression; Humans; Mental Disorders; Migrain | 1989 |